PCORI is authorized by Congress to conduct research to provide information about the best-available evidence to help patients and their health care providers make better-informed health and healthcare decisions. PCORI’s research, which is guided by input from stakeholders across the healthcare community, is intended to give patients and those who care for them with a better understanding of the prevention, treatment and care options available, and the science that supports those options. PCORI is committed to improving health by substantially increasing the quantity, quality, and timeliness of useful, trustworthy information available to support health decisions; speeding the implementation of patient-centered knowledge into practice; and influencing clinical and health care research funded by others to be more patient-centered. For PCORI more information about PCORI, sign up for our email newsletters via www.pcori.org/signup or follow us on Twitter at @PCORI: http://bit.ly/1gix7t5.
DayTwo provides personalized Medical Nutrition Therapy to enable the normalization of blood sugar levels based on an individual’s unique gut-microbiome profile.
Our science rests on 10 years of evidence-based research completed at the Weizmann Institute of Science, published in Cell and later validated by the Mayo Clinic in JAMA. It concluded blood sugar levels in response to foods are highly individualized and therefore can positively impact people with Type II Diabetes.
The nutrition solution, which includes carbs as 30-35% of the personalized recommendations, reduces impact on lifestyle and eliminates negative and significant health risks associated with fad diets, including the ketogenic diet, while increasing adherence and positively impacting blood sugar.
Novo Nordisk, a global health care company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get chronic diseases, everyone is diagnosed, and all patients receive adequate treatment
Employers can get new ways to fight chronic conditions in the workplace, ensure safety and productivity, and drastically lower healthcare costs. Healthcare providers can access faster, more accurate diagnoses—while getting the data they need to better treat their patients. Sleep-deprived people everywhere can stop playing doctor’s-office runaround and more easily get the relief they need to lead healthier, happier lives.
It’s time to wake up to a brighter world with SleepCharge by Nox Health.
Vida’s award-winning, evidence-based virtual polychronic care platform brings together the power of human connection, psychology, and expertise to drive the long-term behaviors that lead not only to better management of chronic conditions, but prevention and even reversal as well. The program is a mobile-first experience uniquely personalized to each user through a combination of provider expertise and machine learning algorithms that use data from 100+ app and device integrations, as well as medical claims data, biometric data, and more to personalize the program and content.
Vida is polychronic by design and so naturally offers programs to treat a full spectrum of chronic conditions and the behavioral conditions that accompany them. Vida’s program offerings are grounded in the belief that every chronic condition is also a behavioral condition, and that good health follows good habits. Vida’s users accomplish lasting results through treating the body and the mind.